|
|
| Aug. 27 |
South SF |
Cell Genesys Drug Trial Halts| Shares plunged more than 70% after a clinical trial of its cancer vaccine Gvax was stopped due to a higher number of deaths among patients | |
|
| Aug. 21 |
Genentech |
Retention plan to cost $371 million An employee retention plan announced along with its rejection of Roche's buyout offer will cost the biotechnology giant about $371 million
|
| Aug. 17 |
Genentech |
Recruiters eye Genentech employees While Roche mulls whether to raise its offer price for biotechnology powerhouse, many prized Genentech professionals
|
| Aug. 13 |
Genentech |
Genentech rejects Roche's $43.7b bid| Biotechnology giant rejected a buyout offer from its majority owner Roche but said it is open to a higher takeover bid | |
|
| Aug.6 |
San Francisco |
Pfizer moving biotech research unit to S.F.| The world's largest drugmaker will move the headquarters of its new biotech research unit to Mission Bay, next door to UCSF's new campus | |
|
|
| Jul.31 |
Genentech |
Shareholders sue to halt Roche buyout Shareholders' attorneys are asking a court to invalidate long-standing agreements between Genentech and its majority owner
|
| Jul.25 |
Genentech |
Panel to ponder Roche takeover offer Genentech has set up a committee of independent directors to consider Swiss drugmaker offer to acquire all shares it does not already own
|
| Jul.21 |
Genentech |
Roche Offers $44B For Remaining Shares Roche Holding, which already owns 55.9%, was offering $43.7 billion to take over the remaining shares of Genentech
|
|
| Jun.12 |
Foster City |
Invitrogen to buy Applied Biosystems| Invitrogen agreed to pay $6.4 billion in cash and stock for scientific instruments maker Applera's Applied Biosystems Group | |
|
|
| May.20 |
San Jose City Hall |
McKesson Sued On Prices The city is suing McKesson over allegations the nation's largest prescription drug distributor fixed prices on hundreds of name-brand drugs
|
| |
Silicon Valley janitors strike
|
|
| Apr.30 |
Genentech |
Bad news on cancer drug Rituxan Shares in Genentech sagged, after the company said Rituxan failed to curb symptoms of the debilitating autoimmune disorder
|
| Apr.24 |
Genentech |
Court slashes $200 million from judgment The company has been ordered to pay $500 million to a Southern California hospital for failing to pay royalties
|
|
| Feb.22 |
Genentech |
FDA Clears Avastin for Breast Cancer A Genentech drug received federal approval, a surprise decision
|
| Feb.17 |
South SF |
Prostate cancer vaccine shows promise
|
|
| |
Rogue trader to cost SocGen $7bn
|
| Jan.14 |
Genentech |
4Q Profit Rises 6 Percent
|
|
| Dec.5 |
Genentech |
FDA Panel Rejects Avastin, stock drops Shares dropped nearly 9% after a panel of medical experts said FDA should deny approval of the company's blockbuster drug
|
| Nov.20 |
Mountain View |
Startup 23andMe offers DNA scans online
|
| Oct.16 |
Genentech |
3Q Profit Up 21 % On Cancer Drug Sales
|
| Oct.12 |
Oakland |
Nurses Not Allowed To Return After Strike
|
| Aug.3 |
Genentech |
Genentech completes Tanox acquisition |
|
| |
Ex-execs in SEC sights
|
| Apr.12 |
Hayward |
Teachers Resume Strike After Talks Fail |
|
| Mar.24 |
Genentech |
Genentech projects quarter to be 'flat' |
|
| Jan.26 |
Genetech |
Genetech Slips After Stroke Warning |
|
| Jan.25 |
San Francisco |
McKesson's 3rd Qtr. Profit Rises 26% |
|
| |
Fed Probe Jobs' Stock-Options Grant
|
|
| Dec.21 |
Genentech |
Genentech gets rights to drug |
|
| Nov.11 |
Genentech |
Genentech to acquire partner Tanox
|
| Sep.12 |
Genentech |
Avastin approval slowed by FDA |
|
| Aug.25 |
Mountain View |
ChemoCentryx signs Glaxo deal |
|
| Aug.12 |
Genentech |
Cancer drug review extended
|
| Aug.8 |
Genentech |
Genentech has plans to expand |
|
| Jul.31 |
Genentech |
Tony Blair Visits Genentech Headquarters
|
| Jul.11 |
Genentech |
2Q Profit Soars to $531 Million
|
| Jul.1 |
Genentech |
FDA approves blindness drug
|
| Jun.29 |
Genentech |
2 drugs set to fight blindness |
|
| Apr.12 |
Genentech |
Profit climbs by 48% in first quarter
|
| Feb.13 |
Genentech |
Cancer Drug Trials Scaled Back
|
| Jan.28 |
San Carlos |
Nektar Develops Inhaled Insulin
|
| Jan.11 |
Genentech |
Up 64% in quarter after good year
|
|
| Nov.1 |
Emeryville |
Novartis to buy Chiron| Chiron's board accepted a $5.1 billion purchase offer from Swiss pharmaceutical giant Novartis AG | |
|
| Oct.18 |
Emeryville |
Problems Cause Chiron To Miss Earnings
|
| Oct.13 |
Emeryville |
Chiron gets OK on flu shots
|
| Jul.11 |
Genentech |
Profits Soar 73% in 2Q
|
| Jun.15 |
Emeryville |
Chiron Warns on Fewer Flu Vaccines Chiron will not produce as many flu vaccines as previously announced because of production delays
|
| Apr.16 |
Genentech |
Avastin helps those with breast cancer
|
| Apr.12 |
Genentech |
Biotech giant's profit up 61%
|
| Mar.5 |
San Francisco |
Sirna Therapeutics moving to Mission Bay
|
| Mar.2 |
Emeryville |
Regulators Lift Suspension on Chiron British regulators are enabling the company to begin reproducing flu drugs
|
| Jan.26 |
Emeryville |
Chiron's 2004 income falls dramatically Chiron hobbled by its failure to deliver half the nation's flu vaccine last year. It missed analysts' expectations
|
| Jan.10 |
Genentech |
4th best place to work for in U.S.
|
| |
Genentech |
Profit surges, misses expectations by 1c
|
|
| Nov.29 |
Genentech |
Avastin helps sickest patients
|
| Nov.4 |
Brisbane |
VaxGen gets contract for anthrax vaccine The government is purchasing 75 million doses of a new generation vaccine under an $877.5 million
|
| Oct.20 |
Emeryville |
Flu Vaccine Fiasco Costs Chiron Millions
|
| Oct.15 |
Emeryville |
Board member quits embattled Chiron
|
| Oct.13 |
Emeryville |
SEC probes Chiron over flu shot shortage |
|
| Oct.6 |
Genentech |
Profits surge on drug sales |
|
| Oct.5 |
Emeryville |
Flu maker Chiron slashes profit outlook Chiron cut its profit forecast by more than half after British officials pulled the company's license
|
| |
Hotel workers begin two-week strike
|
| Aug.26 |
San Jose |
Bioscience Incubator welcomes companies |
|
| Aug.16 |
Orinda |
Top Chiron lawyer's home vandalized |
|
| Jun.8 |
SF Downtown |
150 protesters held at biotech conference About 200 demonstrators failed to shut down the annual Biotechnology Industry Organization convention
|
| |
SF Downtown |
Protesters arrested at biotech conference |
|
| Jun.6 |
SF Downtown |
Biotech conference opens
|
| Apr.7 |
Genentech |
Profits surge on brisk cancer drug sales |
|
| Feb.26 |
Genentech |
FDA approves cancer fighter Avastin |
|
| |
Scientists cloned human embryos
|
| Jan.14 |
Genentech |
Profits surge on strong drug sales |
|
|
| Dec.16 |
Emeryville |
Chiron sells 375,000 additional flu vaccine |
|
| Nov.5 |
South SF |
Pain Therapeutics: 'abuse-resistant' pill |
|
| Oct.8 |
Genentech |
Biotech titan posts higher profits |
|
| Sep.3 |
Brisbane |
VaxGen to supply anthrax vaccine to UK |
|
| Aug.15 |
Fremont |
Firm: Genentech refuses to share profits |
|
| |
Schwarzenegger to run for governor
|
| May.19 |
Genentech |
Encouraging results with cancer drug Avastin extended the lives of some of the colon cancer patients. Company's stock soaring nearly 45%
|
| May.14 |
San Francisco |
Ex-Red Herring editor to launch magazine |
|
| May.12 |
Genentech |
Arthritis drug fails key experiment |
|
| Apr.4 |
Foster City |
Company ships AIDS drug to Africa |
|
| Mar.20 |
Emeryville |
Chiron names new chief executive |
|
| Feb.23 |
Brisbane |
AIDS vaccine developed by VaxGen An experimental vaccine does not protect most people, but showed promise in protecting blacks and Asians
|
| Feb.10 |
Sunnyvale |
Johnson & Johnson to buy Scios |
|
|
| Sep.10 |
Genentech |
Stock plummets 9.7% |
|
| Sep.7 |
Genentech |
Big patent win vs. Chiron
|
| |
Bush wants new laws on corporate abuse
World News 
USA 
Bay Area 
Business 
Bio Tech
Bio Tech & Bio Science (6)
Bio Tech & Business Lawsuit (12)
Bio Tech & Earnings (30)
Bio Tech & Merger (13)
Bio Tech on Wikipedia
Bio Tech on Web
Bio Tech Books
Real Estate
Chart
World Bio Tech News Timeline
Real Estate: